During a live event, Jack Khouri, MD, discussed options for patients with multiple myeloma after relapse and choices to ...

The treatment landscape for multiple myeloma has shifted since European ... reviewed the treatment landscape at the National Comprehensive Cancer Network (NCCN) 2023 Annual Conference.

Sarclisa was added to the National Comprehensive Cancer Network (NCCN) guidelines for non-transplant multiple myeloma candidates as a category 1 (preferred) option alongside VRd and Darzalex plus ...

Cancer patients may have an increased risk of developing second primary malignancies after immune checkpoint inhibitor therapy.

The National Comprehensive Cancer Network celebrated its 30 th anniversary ... including colorectal, lung, prostate, multiple myeloma, mesothelioma, gastrointestinal, gynecologic, and head and ...

The National Comprehensive Cancer Network celebrated its 30 th anniversary with a series of presentations on cancer care practice changes-in both treatment and administration-plus new research, and ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

Researchers at the VIB-UGent Center for Medical Biotechnology have discovered a promising strategy to improve treatment ...